Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,207 | -72,636 | -48,001 | -23,908 | -88,853 |
| Depreciation Amortization | 443 | 388 | 142 | 169 | -1,194 |
| Income taxes - deferred | 511 | 102 | 68 | 34 | 23 |
| Accounts payable and accrued liabilities | -512 | 798 | 701 | 630 | -367 |
| Other Working Capital | -321 | -869 | -2,234 | -4,303 | 4,381 |
| Other Operating Activity | 13,910 | 9,124 | 6,004 | 2,938 | 15,994 |
| Operating Cash Flow | $-82,176 | $-63,093 | $-43,320 | $-24,440 | $-70,016 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -298,043 | 51,959 | 27,459 | 1,959 | -12,368 |
| PPE Investments | N/A | N/A | N/A | N/A | -42 |
| Investing Cash Flow | $-298,043 | $51,959 | $27,459 | $1,959 | $-12,410 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 743,746 | 398 | 398 | 74 | 164,383 |
| Other Financing Activity | -235 | -6 | -6 | -6 | -388 |
| Financing Cash Flow | $743,511 | $392 | $392 | $68 | $163,995 |
| Exchange Rate Effect | 16 | 1 | -4 | -3 | -56 |
| Beginning Cash Position | 161,439 | 161,439 | 161,439 | 161,439 | 79,926 |
| End Cash Position | 524,747 | 150,698 | 145,966 | 139,023 | 161,439 |
| Net Cash Flow | $363,308 | $-10,741 | $-15,473 | $-22,416 | $81,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,176 | -63,093 | -43,320 | -24,440 | -70,016 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -42 |
| Free Cash Flow | -82,176 | -63,093 | -43,320 | -24,440 | -70,058 |